The treatment of chronic progressive multiple sclerosis with cladribine

Proceedings of the National Academy of Sciences of the United States of America

Volumn 93, Issue 4, 1996, Pages 1716-1720

  Beutler, E ^a   Sipe, J C ^a   Romine, J S ^a   Koziol, J A ^a   Mcmillan, R ^a   Zyroff, J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

2 chlorodeoxyadenosine; crossover; deoxypurine; double blind study; immunosuppression

Indexed keywords

ACICLOVIR; CARBAMAZEPINE; CD4 ANTIGEN; CD8 ANTIGEN; CLADRIBINE; PHENYTOIN;

ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEMYELINATING DISEASE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEPATITIS B; HERPES ZOSTER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTIOUS COMPLICATION; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADULT; CLADRIBINE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0029983154     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.93.4.1716     Document Type: Article

References (24)

1. Ford, H. C. (1987) Med. Hypotheses 24, 201-216.
2. Weiner, H. L. & Hafler, D. A. (1988) Ann. Neurol. 23, 211-222.
3. Carson, D. A., Wasson, D. B., Taetle, R. & Yu, A. (1983) Blood 62, 737-743.
4. Carson, D. A., Wasson, D. B. & Beutler, E. (1984) Proc. Natl. Acad. Sci. USA 81, 2232-2236.
5. Carson, D. A., Wasson, D. B., Kaye, J., Ullman, B., Martin, D. W., Jr., Robins, R. K. & Montgomery, J. A. (1980) Proc. Natl. Acad. Sci. USA 77, 6865-6869.
6. Beutler, E. (1994) Semin. Hematol. 31, 40-45.
7. Sipe, J. C., Romine, J. S., Koziol, J. A., McMillan, R., Zyroff, J. & Beutler, E. (1994) Lancet 344, 9-13.
8. Poser, C. M., Paty, D. W., Scheinberg, L., McDonald, W. I., Davis, F. A., Ebers, G. C., Johnson, K. P., Sibley, W. A., Silberberg, D.H. & Tourtellotte, W.W. (1983) Ann. Neurol. 13, 227-231.
9. Kurtzke, J. F. (1983) Neurology 33, 1444-1452.
10. Sipe, J. C., Knobler, R. L., Braheny, S. L., Rice, G. P., Panitch, H. S. & Oldstone, M. B. (1984) Neurology 34, 1368-1372.
11. Cohen, J. (1968) Psychol. Bull. 70, 213-220.
12. Goodkin, D. E., Cookfair, D., Wende, K., Bourdette, D., Pullicino, P., Scherokman, B. & Whitham, R. (1992) Neurology 42, 859-863.
13. Jones, B. & Kenward, M. G. (1989) Design and Analysis of Cross-Over Trials (Chapman & Hall, London).
14. Koziol, J. A. & Maxwell, D. A. (1983) Stat. Med. 1, 83-89.
15. Miller, D. H., Barkhof, F., Berry, I., Kappos, L., Scotti, G. & Thompson, A. J. (1991) J. Neurol. Neurosurg. Psychiatr. 54, 683-688.
16. Beutler, E., Koziol, J., McMillan, R., Sipe, J. C., Romine, J. S. & Carrera, C. J. (1994) Acta Haematol. (Basel) 91, 10-15.
17. Goodkin, D. E., Bailly, R. C., Teetzen, M. L., Hertsgaard, D. & Beatty, W. W. (1991) Neurology 41, 20-25.
18. Chiappelli, F., Myers, L. W., Ellison, G. W., Liao, D. & Fahey, J. L. (1991) Int. J. Immunopharmacol. 5, 455-461.
19. Khoury, S. J., Guttmann, C. R., Orav, E. J., Hohol, M. J., Ahn, S. S., Hsu, L., Kikinis, R., Mackin, G. A., Jolesz, F. A. & Weiner, H. L. (1994) Neurology 11, 2120-2124.
20. Moody, D. J., Fahey, J. L., Grable, E., Ellison, G. W. & Myers, L. W. (1987) J. Neuroimmunol. 14, 175-182.
21. Beutler, E. (1992) Lancet 340, 952-956.
22. Liliemark, J., Albertioni, F., Hassan, M. & Juliusson, G. (1992) J. Clin. Oncol. 10, 1514-1518.
23. Juliusson, G., Liliemark, J., Hippe, E., Blichfeldt, P., Wallman, K., Hagberg, H., Stolt, C-M., Bergheim, J., Winquist, L, Hedenus, M., Carlsson, M., Velin, L., Hellquist, L., Kristofferson, R., Ly, B. E. & Väärt, J. (1992) Blood 80, Suppl. 1, 359 (abstr.).
24. Grieb, P., Ryba, M., Stelmasiak, Z., Nowicki, J., Solski, J. & Jakubowska, B. (1994) Lancet 344, 538.